The odds of the condition were increased among recipients of all 4 vaccines studied: Pfizer, Moderna, AstraZeneca, and J&J.
Risk of uveitis recurrence higher in year after COVID vaccination
Published in COVID-19
More from COVID-19More posts in COVID-19 »
- Very few US adults getting new flu, COVID, RSV vaccines, even in nursing homes
- US respiratory virus activity remains low ahead of holiday season
- Antiviral COVID-19 drug molnupiravir tied to large drop in deaths in older patients
- Adults with migraines at higher risk of depression during pandemic, study shows